Systematic review of the effects of pertussis vaccines in children

Vaccine

Volumn 22, Issue 23-24, 2004, Pages 2965-

  Simondon, François ^a  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PERTUSSIS VACCINE;

CHILD; DRUG EFFECT; DRUG EFFICACY; FOLLOW UP; HUMAN; LETTER; PERTUSSIS; POLICY; PRIORITY JOURNAL; PUBLIC HEALTH; PUBLISHING; QUANTITATIVE ANALYSIS; TECHNIQUE;

CHILD; HUMANS; PERTUSSIS VACCINE; VACCINES, ACELLULAR; WHOOPING COUGH;

EID: 3843121040     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.03.006     Document Type: Letter

References (14)

1. Jefferson T., Rudin M., Dipietrantonj C. Systematic review of the effects of pertussis vaccines in children. Vaccine. 21:2003;2012-2023
2. Simondon F., Yam A., Gagnepain J.Y., Wassilak S., Danve B., Cadoz M. Comparative safety and immunogenicity of an acellular versus whole-cell pertussis component of diphteria-tetanus-pertussis vaccines in senegalese infants. Eur J Clin Microbiol Infect Dis. 15:1996;927-932
3. Simondon F., Preziosi M.P., Yam A., Ndiaye E.H.M., Dia M., Kane C., et al. Relative efficacy and safety of a 2-component acellular pertussis vaccine with respect to a whole cell vaccine in rural Senegal. Vaccine. 15:1997;1606-1612
4. Edwards K.M., Decker M.D. Acellular pertussis vaccines for infants. N Engl J Med. 334:1996;391-392
5. Informal consultation on control of pertussis with whole cell and acellular vaccines. CVI/WHO, Geneva; 18-19 May 1998.
6. Fine P. Implications of different study designs for the evaluation of Acellular Pertussis Vaccines. Dev Biol Stand. 89:1997;123-133
7. Petitti D, editor. Meta-analysis, decision analysis and cost-effectiveness analysis. Methods for quantitative synthesis in Medicine. Oxford: Oxford University Press; 1994.
8. Hewlett E.L. Preparation and composition of Acellular Pertussis Vaccines. Consideration of potential effects on vaccine efficacy. Dev Biol Stand. 89:1997;143-151
9. Brown F, Greco D, Mastrantonio P, Salmaso P, Wassilak S. Pertussis vaccine trials. Dev Biol Stand. Basel: Karger; 1997.
10. NIH meeting on duration of efficacy and immunity for the acellular vaccines. Bethesda, USA; 12-14 November 2000.
11. Plotkin S., Andre F., Poolman J., Robbins J., Salisbury D., Wood D. Preclinical and clinical development of new vaccines. Biologicals. 26(3):1998;247-251
12. Halperin S.A. Acellular pertussis vaccines: the next step. Dev Biol Stand. 89:1997;363-365
13. Orenstein W.A. Rapporteur's summary of the symposium. Dev Biol Stand. 89:1997;397-403
14. Olin P, Gustafsson L. Pertussis in Sweden after introduction of acellular pertussis vaccines: a 5-year follow-up. ESPID 21st Annual Meeting. Taormina, Sicily. 9-11 April 2003. http://www.keres.com/espid2003/program/abstaracts/165. doc.